Identification of novel cellular targets in biliary tract cancers using global gene expression technology.
about
Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cellsCrystal structure of Escherichia coli cytidine triphosphate synthetase, a nucleotide-regulated glutamine amidotransferase/ATP-dependent amidoligase fusion protein and homologue of anticancer and antiparasitic drug targetsIncreased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumorsAnalysis of peripheral nerve expression profiles identifies a novel myelin glycoprotein, MP11Detection of IGF2BP3, HOXB7, and NEK2 mRNA expression in brush cytology specimens as a new diagnostic tool in patients with biliary strictures.Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma.Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma.ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complexWhole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinomaDifferential gene expression profiling of cultured neu-transformed versus spontaneously-transformed rat cholangiocytes and of corresponding cholangiocarcinomasProteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneasThe therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancerCharacterization of a novel rat cholangiocarcinoma cell culture model-CGCCACharacterization of gonadal transcriptomes from the turbot (Scophthalmus maximus).A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma.Hydrogen Sulfide and Cancer.Molecular genetics and targeted therapeutics in biliary tract carcinoma.Aberrant promoter hypermethylation in biliary tract carcinoma.Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancerIntrahepatic cholangiocarcinoma progression: prognostic factors and basic mechanisms.mRNA expression of CDH3, IGF2BP3, and BIRC5 in biliary brush cytology specimens is a useful adjunctive tool of cytology for the diagnosis of malignant biliary stricture.Biology of SNU cell lines.Role of endogenous insulin gene enhancer protein ISL-1 in angiogenesis.Gasotransmitters in cancer: from pathophysiology to experimental therapy.A perspective on molecular therapy in cholangiocarcinoma: present status and future directions.Genetics of biliary tract cancers and emerging targeted therapies.Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities.Targeted therapy for biliary tract cancers.Potential biomarkers in gallbladder cancer: present status and future directions.Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma.MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint.Animal PET for thioacetamide-induced rat cholangiocarcinoma: a novel and reliable platform.Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer.Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysisChemotherapy: Gemcitabine alone or plus cisplatin for biliary tract cancer?The potential utility of geminin as a predictive biomarker in breast cancer.A CTP Synthase Undergoing Stage-Specific Spatial Expression Is Essential for the Survival of the Intracellular Parasite Toxoplasma gondii.Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study.
P2860
Q24628890-74A3E3DD-9137-4D0C-B4AF-9A01F1C72A81Q24629725-CAB416BB-EE94-4E16-AA50-3A70181F4175Q28283996-31B08FFE-DA89-42AA-99A3-42E5BFC9441DQ28565981-6D191BA7-0690-45CF-BFAF-00E2296470A4Q31081531-98CA0050-A09F-444E-A137-29150A907C5AQ33214805-5DCA70DE-A6A2-4B35-9825-F5EE925B1D69Q33805874-CF67A8AB-E096-47CA-9F8B-EEEBE3DAFFB5Q33824237-FBFB4C64-5B61-4206-ADEE-65D5BE9BD1E8Q34016520-5DADD237-991C-46F3-BED4-063E03956372Q34102283-E97C3197-766B-4156-8EB6-53C6241CDBA2Q34311704-30E7419A-8928-4EE5-B511-CE8ADE1AC07AQ34598912-3EB16EB5-B9EF-4ED8-BCDD-82E10ABF3C94Q35016080-807197C8-0501-45A8-ABDB-C11BEBC27B8EQ35085981-C3CC6944-FB3E-493E-B993-81FAF7859D41Q35888668-802B044E-E973-4F06-9200-61B2F75C6C63Q35934963-5B02FCF9-6563-4A00-85DC-32756FE7D662Q36130078-BE646200-E93B-4CD6-A66B-142CC26DA4A5Q36336507-B11A0617-CFB4-4F11-83B6-41D9573F2723Q36488070-C117F657-B839-450A-BA69-BF60E5944CD0Q36542836-A8F7B31C-9E85-447A-A9CF-E52E388E9615Q37049363-9F2881BA-E750-4A5B-B22D-AE3AD2E621BAQ37226551-F1DDF45C-53E1-4A12-A101-99874C722FE9Q37328136-7DF0533B-7FD8-4242-84F9-E71904A6D6A0Q37447033-395B9EF5-08AF-4717-9054-E5D4BDBB78B1Q37470219-0198847C-D14A-4ED6-91D6-DFC6EC77D983Q37656625-CD74F637-7629-4827-B577-F791B89A167DQ37719383-EA200AFE-EA24-4E3C-ABF7-327D1FAE4E5CQ37765099-B69695A3-EA10-4A9D-961C-21CA61009284Q37833005-75461F07-C606-4DFB-85DE-04C408F2EF8BQ37982650-31BF14E2-52EB-45ED-AED7-7C73720B1308Q38038882-6BC557E2-3F8F-4C09-A34A-6C5EA65154C7Q38818452-14FB381B-8CCA-4441-AA0E-423B1C5D780BQ39015995-C102ED11-4684-4524-A747-7F22E2DBC616Q40089941-485BA75B-D59B-4438-9483-4A313BFBFF3AQ40399436-532C7F93-A394-4F5A-81F9-860DE10025AFQ42003931-2B9E9A30-8925-40FA-AC60-06A993C314DDQ42874420-5B6DCC3F-9A51-49A7-AC0E-78AD7F0BAE7AQ44971609-0CDEF608-8053-4EE9-8A14-912EF33D0760Q52603519-F6941664-00A2-4E34-92C3-0569E4787063Q52661828-28757816-FC63-4EE6-9901-BBE7AAB3B434
P2860
Identification of novel cellular targets in biliary tract cancers using global gene expression technology.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Identification of novel cellul ...... al gene expression technology.
@ast
Identification of novel cellul ...... al gene expression technology.
@en
type
label
Identification of novel cellul ...... al gene expression technology.
@ast
Identification of novel cellul ...... al gene expression technology.
@en
prefLabel
Identification of novel cellul ...... al gene expression technology.
@ast
Identification of novel cellul ...... al gene expression technology.
@en
P2093
P2860
P1476
Identification of novel cellul ...... al gene expression technology.
@en
P2093
Anirban Maitra
Ayman Rahman
Donna E Hansel
Jae-Gahb Park
Joseph Geradts
Keith D Lillemoe
Kohje Miyazaki
Lesleyann Hawthorne
Manuel Hidalgo
P2860
P304
P356
10.1016/S0002-9440(10)63645-0
P407
P577
2003-07-01T00:00:00Z